Ondansetron
- Product NDC
- 43063-273
- 11-digit product format
- 430630273
- Labeler code
- 43063
- Product ID
- 43063-273_48d4d97e-6683-3407-e063-6294a90a9e72
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ondansetron
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA078152
- Marketing category
- ANDA
- Marketing start
- 2007-06-27
- Substance
- ONDANSETRON
- Active strength
- 8 mg/1
- Pharmacologic classes
- Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ondansetron
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ONDANSETRON | 8 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 4AF302ESOS |
| Rxcui | 312087 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 43063-273-04 | Ondansetron | 4 in 1 BOTTLE, PLASTIC | TABLET, ORALLY DISINTEGRATING | 4 | | 23 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43063-273 | ONDANSETRON TABLET, ORALLY DISINTEGRATING [PD-RX PHARMACEUTICALS, INC.] | 21 | Current NDC, Legacy NDC, 1 package rows | 20241012_d117de5f-64e5-464c-b782-de0f07e66c8e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43063-273-04 | 43063027304 | 4 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (43063-273-04) | 2011-01-27 | 0000-00-00 | No | No | Current |